Introduction
The calpain family of calcium-dependent cytosolic proteases regulates multiple cellular functions such as spreading and migration, cell death, transcription and signaling (Goll et al., 2003) . Its involvement in a multiplicity of complex pathologies such as muscular dystrophies, neurodegeneration, type II diabetes and cancer has been well documented (Zatz and Starling, 2005) , although its role in the pathogenesis and disease progression has not been completely clarified. Understanding the pathways modulated by calpain might be instrumental in exploiting calpain inhibition as a therapeutic strategy against cancer. Besides the involvement of calpain in cell death (Goll et al., 2003) , we and others have observed a pro-survival role of this protease in tumor-derived cell lines in response to chemotherapeutic drugs and to starvation (Demarchi et al., 2005 (Demarchi et al., , 2006 Guan et al., 2006; Tan et al., 2006; Darnell et al., 2007) , a condition usually occurring in tumors.
Most of the cellular calpain activity is due to the ubiquitous micro-and milli-calpain, requiring microand millimolar calcium concentrations, respectively, for its function. Ubiquitous calpains are heterodimers consisting of an 80-kDa catalytic subunit and of a common 28-kDa regulatory subunit, calpain small-1 (CAPNS1), encoded by CAPNS1 gene (Goll et al., 2003) , required for function (Arthur et al., 2000) .
One of the key regulators of cell survival and growth is the PI3K/Akt pathway. Its activation occurs through phosphorylation by phosphoinositidedependent kinase-1 (PDK-1) at Thr 308, and by mTORC2 (mammalian target of rapamycin complex) at Ser 473, allowing the activation of the mTORC1 complex, which sustains protein synthesis and consequently cell growth, and the inactivation of proteins involved in growth control and apoptosis such as Bad and FoxO (Manning and Cantley, 2007) . PTEN (phosphatase and tensin homolog deleted from chromosome ten) antagonizes PI3K function, consequently inhibiting downstream signaling through Akt. Moreover, Akt is directly inhibited by PHLPP (PH domain leucine-rich repeat protein phosphatase), which dephosphorylates Ser 473 (Gao et al., 2005) , and by protein phosphatase 2A (PP2A), which targets Thr 308 and Ser 473 (Sato et al., 2000; Resjo et al., 2002; Rocher et al., 2007) .
Downstream molecules of Akt include the FoxO family of transcription factors. In mammals, there are three FoxO genes with overlapping functions: FoxO1, 3A and 4, which regulate a number of target genes involved in cell cycle arrest such as p21 and p27Kip1, apoptotic molecules such as Bim, Puma and TRAIL (TNF-related apoptosis-inducing ligand), and reactive oxygen species-detoxifying genes such as catalase and MnSOD (Greer and Brunet, 2005; van der Horst and Burgering, 2007) . Simultaneous deletion of FoxO1, 3A and 4 leads to a progressive cancer-predisposed condition characterized by thymic lymphomas and hemangiomas (Paik et al., 2007) , demonstrating the importance of FoxO as tumor suppressors. Akt phosphorylation promotes FoxO binding to 14-3-3 and its retention in the cytoplasm. On Akt inactivation, FoxO is dephosphorylated and translocates to the nucleus activating transcription (Biggs et al., 1999; Brunet et al., 1999; Kops and Burgering, 1999; Tang et al., 1999) . Overactivation of the PI3K/Akt pathway has been reported in a number of tumors, which is due to both excess of stimulation and reduced phosphatase activity (Altomare and Testa, 2005) . PTEN is deleted in numerous tumors such as prostate and breast carcinomas (Li et al., 1997; Altomare and Testa, 2005) ; moreover, FoxO has been implicated in growth factor withdrawal-induced apoptosis (You et al., 2006; Yan et al., 2008) and in amyloid-beta-induced cell death (Yin et al., 2006) . PP2A positively regulates FoxO both indirectly, through Akt (Trotman et al., 2006; Yin et al., 2006) , and directly, by dephosphorylation both of FoxO1 (Yan et al., 2008) and FoxO3A (Barreyro et al., 2007) , leading to FoxO-dependent cell death (Yin et al., 2006; Barreyro et al., 2007; Yan et al., 2008) . PP2A is predominantly present as a heterotrimer composed of a scaffolding subunit (A), a catalytic subunit (C) and a variable regulatory subunit (B). The regulatory subunits belong to four major unrelated families (B, B 0 , B 00 and B 000 ), and are believed to confer substrate specificity to the enzyme (Janssens and Goris, 2001) . PP2A is an important tumor suppressor targeted by inactivating mutations (Sablina et al., 2007) and by viral oncoproteins in many tumors (Mumby, 2007) . Inhibition of PP2A can lead to cell survival or death depending on the cellular context and the growth conditions, indeed polyoma small-Tmediated PP2A inhibition can promote cell death in complete medium, whereas it allows survival upon serum withdrawal, in an Akt-dependent manner (Andrabi et al., 2007) .
Results

Starvation induces apoptosis in CAPNS1 knockout fibroblasts
We have reported that the lack of calpain activity sensitizes cells to death induced by a variety of stimuli, including growth factors and nutrient starvation (Demarchi et al., 2005 (Demarchi et al., , 2006 (Demarchi et al., , 2007 . To investigate the involvement of caspase activation, CAPNS1 knockout (KO) and wild-type (WT) mouse embryonic fibroblasts (MEFs) were treated with a medium lacking both amino acids and serum (Earle's balanced salt solution (EBSS)) at different points of time, then the lysates were collected and analysed for the presence of the caspase 3 active fragment, a well-established apoptotic marker. As shown in Figure 1a , caspase 3 active fragment is detectable after 4 h treatment in CAPNS1 KO MEFs, whereas it is barely visible at 10 h of treatment in WT MEFs, confirming that CAPNS1 KO MEFs are more prone to apoptosis than WT counterparts. To verify whether CAPNS1 is responsible for the reported cell death, we performed a similar experiment in CAPNS1 KO cells stably expressing rat CAPNS1 R, in which calpain activity is partially restored (Dourdin et al., 2001) . CAPNS1 KO, WT and CAPNS1 R were incubated with EBSS for 16 h, then they were stained with Annexin V-fluorescein isothiocyanate (FITC) and analysed by flow cytometry. The histogram reported in Figure 1b confirms the increased sensitivity of CAPNS1 KO cells compared with WT MEFs; in addition, CAPNS1 reintroduction diminishes the percentage of apoptotic cells. The reduced sensitivity to EBSS-induced apoptosis in CAPNS1 R MEFs compared with KO ones was further confirmed by the detection of caspase 3 active fragment by western blot (Figure 1c ).
FoxO transcription factors are more active in CAPNS1 MEFs
We hypothesized that the increased sensitivity to cell death observed in CAPNS1 KO MEFs could be partially due to an increased activation of FoxO, as these cells are partially defective in Akt activation in response to TNF-alpha and staurosporine (Tan et al., 2006) .
To evaluate whether FoxO transcription factors were more active in the absence of calpain activity, CAPNS1 KO and WT MEFs were transfected with a luciferase reporter construct bearing FoxO-binding sites in the promoter together with a Renilla-expressing plasmid for normalization. After 24 h, the cells were stimulated with EBSS for 4 or 8 h, or left in complete medium, then luciferase activity was detected. The histogram shown in Figure 2a indicates that FoxO-dependent luciferase activity is higher in CAPNS1 KO than in WT MEFs, both in complete medium and in EBSS. To investigate the involvement of FoxO3A in this response a dominant-negative FoxO3A (DN-FoxO3A) was co-expressed. As shown in Figure 2a , DN-FoxO3A is able to reduce FoxO luciferase activity in CAPNS1 KO cells both in basal conditions and on EBSS treatment, suggesting that FoxO3A is partially responsible for the observed transcriptional activation. A similar experiment was performed with ectopic FoxO1 and FoxO3A. The histogram reported in Figure 2b indicates that both FoxO transcription factors appear more active in CAPNS1 KO cells in complete medium and in EBSS. FoxO3A appears always more active than FoxO1 in CAPNS1 KO cells. To further verify whether CAPNS1 is responsible for the downregulation of FoxO-responsive promoter a plasmid encoding Figure 2c indicates that the presence of CAPNS1 reduces EBSS-induced FoxO3A activation. Conversely, transfection of calpastatin, calpain endogenous inhibitor, along with FoxO3A in WT cells increases FoxO3A transcriptional activity in EBSS medium ( Figure 2d ). Furthermore, both p27Kip1 and Bim, two FoxO endogenous target genes, are more efficiently induced by EBSS in CAPNS1 KO than in WT MEFs (Figure 2e ), although the basal protein level of p27Kip1 is higher in WT cells. The experiment was performed three times, analysed statistically, and the difference in Bim expression relative to actin between CAPNS1 and WT cells is reported in Supplementary Figure 1a . In CAPNS1 KO cells, the expression of Bim is significantly more induced than in WT cells, further supporting a role of calpain in FoxO regulation.
The kinetics of FoxO3A dephosphorylation and nuclear translocation is faster in CAPNS1 KO cells As FoxO activation is often associated with a decrease in phosphorylation followed by nuclear translocation, we evaluated the phosphorylation level of Thr 32, a site phosphorylated by Akt, resulting in FoxO inhibition (Brunet et al., 1999) . CAPNS1 KO and WT cells were treated with EBSS for 5, 10 or 20 min or left in complete medium, and the phosphorylation of Thr 32 at every time point was evaluated by western blot (Figure 3a) . Thr 32 basal phosphorylation is slightly reduced in CAPNS1 KO cells compared with WT ones, and on EBSS treatment it disappears more promptly than in WT cells; in parallel also Akt appears to be less phosphorylated both at Thr 308 and Ser 473 in CAPNS1 KO MEFs, and in response to EBSS it is dephosphorylated more quickly.
We further evaluated FoxO nuclear translocation by immunofluorescence. CAPNS1 KO and WT MEFs were Figures 1c and 1d) . Altogether, the above data suggest that the lack of CAPNS1 is linked to an increase in FoxO activation both in basal conditions and following starvation. To further verify such increase in FoxO activity, electrophoretic mobility shift assay assays were performed with nuclear extracts prepared from CAPNS1 KO and WT cells using an oligonucleotide bearing FoxO-binding sites derived from Fas promoter as a probe (Brunet et al., 1999; Yin et al., 2006) . The autoradiography reported in Supplementary Figure 2a shows that CAPNS1 KO MEFs have a higher amount of FoxO-binding activity compared with the WT counterpart. An excess of specific cold competitor oligonucleotide clearly competes for binding and dramatically reduces the retarded bands, whereas a mutated oligonucleotide leaves it unaffected.
Starvation-induced apoptosis of CAPNS1 KO fibroblasts is associated with increased FoxO activity To investigate whether FoxO activation is responsible for the increased apoptosis observed in CAPNS1 KO cells, CAPNS1 KO fibroblasts were infected with pRetroSU-PER encoding an shRNA targeting FoxO3A (Essafi et al., 2005) or empty vector, then they were treated with EBSS. Lysates were collected at different time points and the expression of Bim and caspase 3 was analysed ( Figure 4b ). Figure 4a shows the reduction of FoxO3A expression obtained. As reported in Figure 4b , FoxO3A silencing reduces EBSS-induced Bim upregulation and the associated cell death, as indicated by the reduction of caspase 3 active fragment protein levels accumulating upon FoxO3A silencing. These data strongly argue for a major role of FoxO3A in the increased sensitivity to starvation of CAPNS1 KO fibroblasts.
CAPNS1 depletion increases FoxO3A activation in MCF-7 cells
To determine whether calpain depletion could increase FoxO activation in human cells also, mammary CAPNS1 regulates Akt/FoxO3A through PP2A C Bertoli et al carcinoma MCF-7 cells were transfected with an siRNA targeting CAPNS1 or a control siRNA. After 72 h, a time course of EBSS treatment was performed and lysates were analysed by western blot with an antibody against phospho-Thr 32 of FoxO3A (Figure 5a ). In CAPNS1-depleted cells, FoxO3A dephosphorylation takes place at faster kinetics than in control cells. Consistently, Akt Ser 473 dephosphorylation occurred more quickly, whereas Thr 308 appeared less phosphorylated in all the conditions and did not change significantly.
We further evaluated FoxO activation by fluorescence microscopy. CAPNS1-depleted MCF-7 cells were transfected with GFP-FoxO3A and 24 h later they were treated with EBSS or left in complete medium, then they were fixed and scored for FoxO3A distribution. The histogram reported in Figure 5b shows that also in MCF-7 cells depletion of CAPNS1 leads to an increased nuclear relocation of FoxO in a higher percentage of cells compared with control ones, in both the conditions tested. In parallel, GFP-FoxO3A was immunoprecipitated from CAPNS1-depleted and control MCF-7 cells maintained in complete medium or in EBSS, and Thr 32 phosphorylation was evaluated by western blot.
As revealed in Figure 5c , the level of phosphorylation is reduced in CAPNS1-depleted cells in both conditions, confirming the results obtained in the previous experiment. Similarly, also FoxO1 translocated more quickly into the nucleus in CAPNS1-silenced cells, as shown in Supplementary Figure 2b . On the other hand, pharmacological activation of calpain by thapsigargin treatment (Harriman et al., 2002) reduces FoxO3A dephosphorylation occurring on EBSS treatment ( Supplementary  Figure 3a) .
To further assess the increase in FoxO activation associated with calpain depletion, electrophoretic mobility shift assay analysis was performed. MCF-7 cells were transfected with GFP-FoxO3A and incubated either in EBSS for 1.5 h or in complete medium, in the presence or absence of calpain inhibitor I. Nuclear extracts were prepared and incubated with a radiolabeled FoxO consensus oligonucleotide derived from Fas promoter. The identity of the retarded FoxO3A containing band was assessed through the addition of anti-GFP antibody, as indicated (Supplementary Figure 3b) , and by competing titration with either specific or mutated FoxO cold oligonucleotides (Supplementary Figure 3c) . EBSS treatment efficiently induces FoxO binding. FoxO3A appears more active when calpain is chemically inhibited, particularly in complete medium, indeed the retarded band is more pronounced than in the untreated counterpart.
We then analysed the induction of two FoxO target genes (Figure 5d ), and also in this case on EBSS stimulation, p27Kip1 and Bim protein levels appear to increase more in CAPNS1-depleted cells compared with the control ones. The experiment was repeated three times and the increase in Bim expression in CAPNS1-depleted cells compared with control ones was analysed statistically, as represented in the histogram reported in Supplementary Figure 3d .
To evaluate the effect of calpain depletion on EBSSinduced death, MCF-7 cells were transfected with CAPNS1 siRNA or with a control siRNA, after 72 h they were treated with EBSS for 20 h, stained with propidium iodide and Annexin V and analysed by flow cytometry. The plots reported in Figure 5e indicate that MCF-7 cells are more sensitive to starvation, when CAPNS1 is depleted, confirming the results observed in murine fibroblasts. Next, we tested whether other mammary carcinoma cell lines were also sensitive to calpain inhibition. In particular, T47D and MDA-MB468 cells were treated with calpain inhibitor I, and Bim protein levels and the appearance of PARP-cleaved fragment were analysed by western blot. As reported in Supplementary Figure 3e , Bim protein levels increase and PARP cleavage is induced following calpain inhibition, strongly suggesting that calpain inhibition is associated with apoptosis induction.
CAPNS1 modulation of FoxO involves PP2A
The data reported above suggest that calpain could modulate FoxO through Akt regulation, as Akt appears to be less phosphorylated in the absence of calpain activity (Figures 3a and 5a ). We therefore hypothesized that there could be a phosphatase activity more CAPNS1 regulates Akt/FoxO3A through PP2A C Bertoli et al pronounced in CAPNS1 KO MEFs compared with WT cells, because we did not observe any differences in PDK-1 phosphorylation between the two cell lines. To evaluate the involvement of PP2A in the increased FoxO3A activity observed in CAPNS1 KO cells, okadaic acid (OA), a PP2A inhibitor (Millward et al., 1999) , was employed. As a first approach, we performed a FoxO reporter luciferase assay in CAPNS1 KO and WT cells transfected with FoxO3A; 24 h after transfection, the cells were treated with EBSS or left in complete medium in the presence of different concentrations of OA. The histogram shown in Figure 6a indicates that in CAPNS1 KO MEFs FoxO3A transcriptional activity is inhibited by OA, suggesting that PP2A could be involved in such activation. We also analysed the subcellular location of FoxO3A and found that OA increased the percentage of cells with cytoplasmic FoxO3A in EBSS both after 15 min treatment ( Figure 6b ) and after 2 h (data not shown). After OA treatment, the percentage of CAPNS1 KO cells with cytoplasmic FoxO3A in EBSS is similar to that observed in WT cells in EBSS, suggesting that an increased phosphatase activity sensitive to OA could be present in the cells lacking CAPNS1. To further investigate the ability of OA to inhibit the increased FoxO3A activation observed in CAPNS1 KO cells, Bim protein levels were analysed by western blot in a time course EBSS experiment. As observed in Figure 6c , treatment with OA reduces the increase in Bim protein level triggered by EBSS, and the associated cell death, as demonstrated by the analysis of caspase 3 active fragment. OA reduces the levels of Bim also in WT cells, as expected (data not shown); however, the induction of Bim in these cells is far less evident than in CAPNS1 KO cells at these time points, as shown in Figure 2e .
To further assess the role of PP2A in FoxO hyperactivation associated with CAPNS1 depletion, we employed a construct encoding a short hairpin targeting the PP2A catalytic subunit to specifically downregulate PP2A activity (Figure 7a ). PP2A catalytic subunit depletion decreases CAPNS1 KO cell death in starvation medium (Figure 7b) , and in parallel it reduces the induction of p27Kip1 (Figure 7c ) and Bim (Figure 7d) , confirming the role of PP2A in FoxO activation in CAPNS1 KO cells.
PP2A B56 subunits are calpain substrates
To gain insight into the molecular mechanism underlying the calpain-PP2A-FoxO axis, we checked whether the lack of CAPNS1 affects PP2A-Akt interaction. Akt was immunoprecipitated from CAPNS1 KO and WT cells and the presence of co-precipitated PP2A was investigated by western blot (Figure 8a ). Akt is highly associated with PP2A in CAPNS1 KO cells than in WT ones, indicating that PP2A is indeed the phosphatase responsible for the reduced Akt activity and the consequent FoxO activation observed in cells lacking calpain activity.
As PP2A global activity was not affected by calpain deletion (data not shown), we hypothesized that some regulatory subunits of the phosphatase with substrate specificity were modulated by calpain, namely the B subunits, which belong to four families: the B (PR55), the B 0 (B56), the B 00 (PR72) and the most recently identified B 000 family. Every family accounts for a number of isoforms, in particular the B56 family involves the alpha, beta, gamma, delta and epsilon members, which share high homology. Interestingly, B56 has been implicated in the modulation of Akt phosphorylation (Van Kanegan et al., 2005; Yin et al., 2006; Rocher et al., 2007) .
As a first attempt to understand whether they could be regulated by calpain, we performed in vitro proteolysis assays. Among the B56 family, we chose to analyse B56 alpha and gamma. The HA-tagged B56 alpha and gamma proteins were immunoprecipitated from CAPNS1 regulates Akt/FoxO3A through PP2A C Bertoli et al previously transfected cells and incubated with or without calpain at different points of time; EGTA was included in a control sample. The western blot reported in Figure 8b clearly indicates that both B56 alpha and gamma are in vitro substrates of calpain and the cleavage can be specifically inhibited by EGTA, which inhibits calpain activity. We also analysed PR55 and PR72 to check whether there was any difference in their regulation by calpain. In vitro translated radiolabeled PR55, PR72 and NF-kB p50, as positive control, were incubated with calpain at different points of time, then the reaction was stopped by the addition of sample buffer and the proteins were separated by SDSpolyacrylamide gel electrophoresis (PAGE). The autoradiography reported in Figure 8c shows that calpain very efficiently degrades PR72, whereas PR55 is resistant to degradation, indicating that these subunits are differently regulated by calpain. We therefore evaluated whether the stability of B56 subunits was affected by calpain also in vivo. MCF-7 cells stably expressing an shRNA targeting CAPNS1 or a control shRNA were treated with cycloheximide for 15 h, to evaluate the stability of the protein, and then B56 alpha protein levels were analysed by western blot. As shown in Figure 8d , CAPNS1 depletion is associated with a slight increase in B56 alpha protein level, which becomes more consistent on cycloheximide addition. These results indicate that calpain may modulate B56 levels in living MCF-7 cells.
The overexpression of B56 alpha and gamma enhances FoxO3A transcriptional activity more consistently in CAPNS1 KO cells than in WT ones, as assessed in luciferase assay (Supplementary Figure 4) , indicating that these subunits are involved in the upregulation of FoxO3A upon calpain deletion.
Discussion
In this paper, we demonstrate that FoxO transcription factors, in particular FoxO3A, are negatively regulated by calpain, and can be therefore activated upon calpain inhibition. Calpain inhibition-mediated FoxO activation is particularly evident upon nutrient withdrawal, a condition that mimics the core of neoplastic lesions, where blood supply is reduced or absent. The activation of FoxO has been demonstrated both in murine CAPNS1 regulates Akt/FoxO3A through PP2A C Bertoli et al fibroblasts and in human mammary carcinoma cell lines, a context where the inactivation of PTEN (Li et al., 1997; Altomare and Testa, 2005) and FoxO has been recognized as a major tumor-promoting event (ReaganShaw and Ahmad, 2006) . Overexpression of active FoxO mutants in PTEN-deficient prostate cancer cells leads to apoptosis (Nakamura et al., 2000) ; moreover, PI3K depletion in mammary carcinoma cell lines causes cell death, which is inhibited by FoxO1 and FoxO3A silencing (Reagan-Shaw and Ahmad, 2006) . FoxOdependent Bim activation is an apoptotic mechanism induced by chemotherapeutics targeting breast carcinoma cells (Sunters et al., 2003) and leukemia cells (Essafi et al., 2005) . The role of FoxO in apoptosis induction has been demonstrated in a number of reports (Brunet et al., 1999; Nakamura et al., 2000; Dijkers et al., 2002; Sunters et al., 2003; Essafi et al., 2005; You et al., 2006; Barreyro et al., 2007) , in line with its tumor suppressor role, and in many instances the induction of cell death correlated with the induction of the pro-apoptotic molecule Bim. In agreement with these reports, we observed a FoxO3A-dependent increase in Bim expression that correlated with the induction of apoptosis in CAPNS1 KO cells, further confirming the importance of FoxO3A and Bim in growth factor withdrawal-induced cell death.
CAPNS1 inhibition is associated with a decrease in Akt phosphorylation, correlating with a reduced FoxO phosphorylation. We demonstrate that the PP2A catalytic subunit is more tightly associated with Akt in calpain-deficient cells compared with WT ones, indicating that this phosphatase plays a major role in the reduction of Akt activity. Moreover, we show that calpain efficiently cleaves B56 alpha and gamma subunits in vitro, and affects B56 alpha stability also in vivo. Notably, B56 subunits have been demonstrated to regulate Akt phosphorylation in many reports (Van Kanegan et al., 2005; Yin et al., 2006; Rocher et al., 2007) . On the basis of our findings, we may speculate that calpain could modulate Akt through the regulation of B56 subunits, and hence PP2A recruitment.
The importance of Akt regulatory mechanisms in tumor suppression has been demonstrated in particular in prostate and breast cancer, where PTEN is often depleted and Akt is hyperactivated (Li et al., 1997; Trotman et al., 2003; Altomare and Testa, 2005) . Recently, Trotman et al. (2006) have highlighted the importance of a PP2A-dependent Akt regulatory mechanism activating FoxO3A to inhibit cell proliferation and survival, in particular in conditions of PTEN depletion.
In this study, we show that in CAPNS1-deficient cells starvation activates a pro-apoptotic pathway relying on a PP2A-mediated FoxO activation, and we provide evidence of a calpain-PP2A-Akt-FoxO regulatory pathway.
The role of PP2A in the regulation of cell death in the absence of serum has been recently addressed (Andrabi et al., 2007) , in line with this study our findings indicate that PP2A has a pro-apoptotic role in the absence of serum in CAPNS1 KO cells, where it contributes to the activation of FoxO. It is, however, possible that calpain affects FoxO also in a PP2A-Akt-independent way.
Calpain is often hyperactivated in tumor cells (Carragher et al., 2004; Libertini et al., 2005) , where it plays a major role in migration and metastasis due to its ability to cleave cytoskeletal proteins. Interestingly, PP2A negatively regulates calpain in nicotine-stimulated cell migration (Xu and Deng, 2006) , in line with its tumor suppressor role. Our findings suggest that calpain negatively affects some specific PP2A functions, particularly those depending on B56 alpha and gamma.
In conclusion, we have demonstrated the existence of a pathway linking calpain, PP2A and FoxO, which could be exploited to induce tumor cell apoptosis.
Materials and methods
Plasmid constructs
Foxo-binding site luciferase construct (6 Â ) (DBE) was kindly gifted by Dr M Sandri (Padova, Italy) (Sandri et al., 2004) , pECE FoxO3A-HA and pECE Dn-FoxO3A were kind gifts by Dr ME Greenberg (Boston, MA, USA) (Brunet et al., 1999) ; pEGFP-FoxO3A was obtained by subcloning the PCRamplified FoxO3A. The pRetroSUPER-shFoxO3A was already described (Brummelkamp et al., 2002) . pSIRENshPP2Ac is a kind gift by Dr Lee JM (St Louis, MO, USA) (Yin et al., 2006) . pEGFP-FoxO1 was donated by Dr Unterman TG (Chicago, IL, USA) (Zhang et al., 2002) . pCEP-B56 constructs (Seeling et al., 1999) , pcDNA-PR55 and pcDNA-PR72 were gifted by Dr D Pim (Trieste, Italy). Flag-CAPNS1 was produced by subcloning human CAPNS1 in pcDNA3/Flag vector. HA-calpastatin was produced by subcloning human calpastatin into pcDNA3 vector.
Cell culture WT and CAPNS1À/À MEFs (Dourdin et al., 2001) were a kind gift of Dr Peter A Greer (Kingston, Ontario, Canada); MCF-7 cells and MEFs were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum.
Transfection and reporter assay MCF-7, CAPNS1À/À and control mouse fibroblasts at 60-80% confluency were transiently transfected using Fugene (Roche Diagnostics GmbH, Mannheim, Germany) or Oligofectamine (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
For reporter assays, cells were transfected with DBE luciferase plasmid and Renilla, together with the indicated plasmids, after 24 h the cells were washed three times and stimulated with EBSS or Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Lysates were harvested in passive lysis buffer (Promega, Madison, WI, USA) at the indicated time points. Luciferase activity was detected with the Dual-Luciferase Reporter Assay System (Promega).
Cell infections
293 Phoenix Ampho packaging cells were transfected with the calcium phosphate method with pRetroSUPER-shFoxO3A, pSIREN shPP2A or vector, after 72 h the supernatant was harvested, filtered and added to CAPNS1 KO fibroblasts. The CAPNS1 regulates Akt/FoxO3A through PP2A C Bertoli et al infected MEFs were selected with puromycin and after 14 days FoxO3A or PP2A expression was checked by western blot.
Western blot immunofluorescence and immunoprecipitation
After washing three times with phosphate-buffered saline, fibroblasts and MCF-7 were incubated with EBSS or complete medium for the indicated times and then lysed. Western blotting was performed according to standard protocols using the following antibodies: anti-FoxO3A, phospho-FoxO3A-Thr 32 and PP2Ac (Upstate Cell Signaling, Lake Placid, NY, USA), Akt detection kit (Cell Signaling Technologies, Danvers, MA, USA), actin and p27Kip1 (Sigma, St Louis, MO, USA), Bim (Pro-Science, Woburn, MA, USA), caspase 3 Asp 175 (Cell Signaling Technologies).
Immunofluorescence was performed by fixing the cells in 3% paraformaldehyde and staining with anti-HA antibody.
Immunoprecipitation was performed with anti-GFP, or Akt antibody according to standard protocols.
Annexin V and propidium iodide staining and fluorescenceactivated cell sorting analysis Translocation of phosphatidylserine to the cell surface was monitored by using an Annexin V-FITC apoptosis detection kit (Sigma-Aldrich) according to the manufacturer's instructions. In total, 15 000 events were collected by FACScalibur (BD Biosciences, San Jose, CA, USA) in list mode manner and analysed by the Cell Quest software.
Electrophoretic mobility shift assay Nuclear extracts and oligonucleotide probes were prepared by standard procedures. Here, 10 mg (MCF-7) or 20 mg (MEFs) of nuclear extracts was incubated with [g-32 P]ATP (Amersham Biosciences Corp., Piscataway, NJ, USA)-labeled FoxOspecific oligonucleotide (Brunet et al., 1999; Yin et al., 2006) and analysed on native 5% gels. Supershift assay was performed by pre-incubating nuclear extracts with anti-GFP antibody for 15 min.
In vitro protease assay 35 S-labeled in vitro translated protein (Promega) and immunoprecipitated products were incubated with 0.005 U/ml microcalpain at room temperature in: 30 mM Tris, pH 7.5, 1.5 mM dithiothreitol, 750 mM CaCl 2 for micro-calpain and 40 mM Tris, pH 7.5, 50 mM NaCl, 1 mM dithiothreitol, 1 mM CaCl 2 for milli-calpain. Reactions were terminated at the indicated time points by adding SDS-PAGE loading buffer and analysed on a 12.5% SDS-PAGE.
Statistical analysis
Results are expressed as means ± standard deviation of at least three independent experiments. Statistical analysis was performed using Student's t-test with the level of significance set at Po0.05.
